Drawing for LISTMIND

USPTO serial 99938461

LISTMIND

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
Law office

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with LISTMIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret A. Boulware

Margaret A. Boulware Boulware & Valoir PLLC2603 Augusta Dr.Suite 135077079, TX 77057

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services, namely, hosting software for use by others for managing electronic mail correspondence and online group discussion forums, organizing communications into searchable message archives, and performing artificial intelligence-based search and summarization of message archives.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Jul 14, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance